# Effect of F2695 on Functional Recovery After Ischemic Stroke

Study · id `cardio:ct-nct01639014` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01639014](<https://clinicaltrials.gov/study/NCT01639014>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01639014

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 532 participants.

## Technical summary

Registry record NCT01639014. Randomized; quadruple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2015-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 532 participants (enrolled count; ClinicalTrials.gov record NCT01639014, source copy `cardio:ctgov-nct01639014-2015-04-01`, retrieved 2026-10-26)
- Start date: 2012-07 (registry gives no type) (ClinicalTrials.gov record NCT01639014, source copy `cardio:ctgov-nct01639014-2015-04-01`, retrieved 2026-10-26)
- Primary completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01639014, source copy `cardio:ctgov-nct01639014-2015-04-01`, retrieved 2026-10-26)
- Completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01639014, source copy `cardio:ctgov-nct01639014-2015-04-01`, retrieved 2026-10-26)
- Countries: Belgium; Czechia; France; Germany; Hungary; Italy; Portugal; Russia; Spain; Sweden; Switzerland (ClinicalTrials.gov record NCT01639014, source copy `cardio:ctgov-nct01639014-2015-04-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01639014-2015-04-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of F2695 on Functional Recovery After Ischemic Stroke
- Acronym: LIFE
- Condition: Ischemic Stroke
- Intervention (Drug): F2695
- Intervention (Drug): placebo
- Lead sponsor: Pierre Fabre Medicament
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 6a3dd3c6086072c7a612391d345b6be30cd27f4ca625f8dc508898c8adef0fa4
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
